Texas · 89th Legislature (2025) · Bill

SB 883: Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.

Passed one chamber Last action April 22, 2025: Referred to Public Health

Plain-language summary

SB 883 is a bill introduced in the Texas Senate on January 23, 2025. According to its official title, it concerns: Relating to patient access to prescription drugs for off-label use for COVID-19 treatment. Primary sponsor: Angela Paxton (Republican), Bob Hall (Republican). It lists 2 additional sponsors. Most recent recorded action (April 22, 2025): Referred to Public Health.

Sponsors

Primary sponsors: Angela Paxton (Republican); Bob Hall (Republican). 2 co-sponsors.